Search Results
Aug 24, 2026, 08:00 ET LEQEMBI IQLIK®(lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer's Disease
July 22, 2026.Amin L, Harris DA. Aβ receptors specifically recognize molecular features displayed by fibril ends and neurotoxic oligomers. Nat Commun. 2021;12:3451. doi:10.1038/s41467-021-23507-z.Ono K, Tsuji M. Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying
More news about: Eisai Inc.
Aug 17, 2026, 14:03 ET ByteLens omvandlar operatörsdata till kunskap som växer över tid
datamiljö. Tillsammans bygger de successivt upp en fördel som ingen konkurrent kan kopiera. Autonomin växer fram ett löst fel i taget, med live-data från nät hos fyra tier 1-operatörer.Det nätet lär sig stannar hos operatören.Om ByteLensByteLens är en AI-native produkt för operativ
More news about: Bytelens
Aug 11, 2026, 10:21 ET LAKE VICTORIA GOLD ANNOUNCES MAIDEN MINERAL RESOURCE AT TEMBO OF 480,100 INFERRED AND 99,700 INDICATED OUNCES, ADJACENT TO BARRICK'S BULYANHULU MINE
PersonThe Technical Report supporting the MRE was prepared by independent Qualified Persons Noleen D. Pauls (M.Sc., Pr. Sci. Nat., FGSSA) and Dean Richards (B.Sc. (Hons), Pr. Sci. Nat., MGSSA) of Obsidian Consulting Services, each a Qualified Person as defined under NI 43-101 and independent of the Company.
More news about: Lake Victoria Gold Ltd.
Aug 07, 2026, 07:00 ET Kimbell Royalty Partners Announces Record Second Quarter 2026 Results
OilNat GasOil
More news about: Kimbell Royalty Partners, LP
Jul 29, 2026, 03:00 ET AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Severe Alopecia Areata
2010;62(2):177-188, quiz 189-190. doi:10.1016/j.jaad.2009.10.032Pratt CH, King LE, Messenger AG, Christiano AM, Sundberg JP. Alopecia areata. Nat Rev Dis Primers. 2017;3(1):17011. doi:10.1038/nrdp.2017.11Davey L, Clarke V, Jenkinson E. Living with alopecia areata: an online qualitative
More news about: AbbVie
Jul 23, 2026, 03:33 ET Lundbeck receives FDA Fast Track designation for Lu AH69593, an investigational orexin 2 receptor agonist for narcolepsy
Burdakov D, et al. Narcolepsy — clinical spectrum, aetiopathophysiology, diagnosis and treatment. Nat Rev Neurol. 2019;15:519–539.Kornum BR, Knudsen S, Ollila HM, et al. Narcolepsy. Nat Rev Dis Primers. 2017;3:16100.Black J, Reaven NL, Funk SE, et al. The Burden of Narcolepsy
More news about: H. Lundbeck A/S
Jul 23, 2026, 03:29 ET Lundbeck receives FDA Fast Track designation for Lu AH69593, an investigational orexin 2 receptor agonist for narcolepsy
Burdakov D, et al. Narcolepsy — clinical spectrum, aetiopathophysiology, diagnosis and treatment. Nat Rev Neurol. 2019;15:519–539.Kornum BR, Knudsen S, Ollila HM, et al. Narcolepsy. Nat Rev Dis Primers. 2017;3:16100.Black J, Reaven NL, Funk SE, et al. The Burden of Narcolepsy
More news about: H. Lundbeck A/S
Jul 22, 2026, 06:50 ET Neurimmune sells a portion of its royalty interest in cliramitug to Royalty Pharma
Engl J Med 2023; 389(3):239.2 Kahr et al., Nature Medicine 2026; in press.3 Michalon et al., Nat Commun 2021; 12(1):3142.About NeurimmuneNeurimmune is a clinical-stage biopharmaceutical company building next-generation antibody
More news about: Neurimmune
Jul 20, 2026, 03:46 ET Lundbeck announces last patient randomized in DEEp OCEAN, a large Phase III trial in developmental and epileptic encephalopathies (DEEs)
LinkedIn.ReferencesScheffer IE, et al. Epilepsia. 2025;00:1-10Scheffer IE et al. Nat Rev Dis Primers 2024;10:61Ren A, et al. J Medicinal Chem. 2025;68(11):10599-10618
More news about: H. Lundbeck A/S
Jul 20, 2026, 03:42 ET Lundbeck announces last patient randomized in DEEp OCEAN, a large Phase III trial in developmental and epileptic encephalopathies (DEEs)
LinkedIn.ReferencesScheffer IE, et al. Epilepsia. 2025;00:1-10Scheffer IE et al. Nat Rev Dis Primers 2024;10:61Ren A, et al. J Medicinal Chem. 2025;68(11):10599-10618
More news about: H. Lundbeck A/S
Jul 17, 2026, 01:25 ET Camurus' NDA resubmission for CAM2029 in acromegaly accepted for review by the US FDA
et al. Global epidemiology of acromegaly: a systematic review and meta-analysis. Eur J Endocrinology. 2021; 185:251-63.Colao A., et al. Acromegaly. Nat Rev Dis Primers. 2019;5(1):20.
More news about: Camurus AB
Jul 17, 2026, 01:22 ET Camurus' NDA resubmission for CAM2029 in acromegaly accepted for review by the US FDA
et al. Global epidemiology of acromegaly: a systematic review and meta-analysis. Eur J Endocrinology. 2021; 185:251-63.Colao A., et al. Acromegaly. Nat Rev Dis Primers. 2019;5(1):20.
More news about: Camurus AB
Jul 15, 2026, 09:50 ET Tanzania's Next Gold Mine Has Its Team, Its Financing, and Its Permits - Now It Just Has to Build
approved by Lake Victoria Gold Ltd. Technical information relating to Lake Victoria Gold Ltd. has been reviewed and approved by David Scott, Pr. Sci. Nat., a Qualified Person as defined by National Instrument 43-101. Mr. Scott is a registered member of the South African Council for Natural Scientific Professions
More news about: USA News Group
Jul 14, 2026, 11:15 ET LEQEMBI® Real-World LEADER Study Presented at AAIC® 2026 Finds Over 75% of Early Alzheimer's Patients Enrolled in the Study Remained Stable and Nearly 7% Improved Over an Average of 17 Months of Treatment
investors.ReferencesAmin L, Harris DA. Aβ receptors specifically recognize molecular features displayed by fibril ends and neurotoxic oligomers. Nat Commun. 2021;12:3451. doi:10.1038/s41467-021-23507-zOno K, Tsuji M. Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying
More news about: Eisai Inc.
Jul 13, 2026, 17:36 ET FDA Approves LEQEMBI IQLIK® (lecanemab-irmb) Subcutaneous Injection as an Initiation Dose for Early Alzheimer's Disease
investors.ReferencesAmin L, Harris DA. Aβ receptors specifically recognize molecular features displayed by fibril ends and neurotoxic oligomers. Nat Commun. 2021;12:3451. doi:10.1038/s41467-021-23507-z.Ono K, Tsuji M. Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying
More news about: Eisai Inc.
Jul 13, 2026, 04:00 ET Eisai Presents Latest Findings Showed Etalanetug Reduced Alzheimer's Disease Tau Tangle-Specific Plasma Biomarker MTBR-tau243 at Alzheimer's Association International Conference® (AAIC®) 2026
https://doi.org/10.1002/alz.13859Horie, K. et al. Plasma MTBR-tau243 biomarker identifies tau tangle pathology in Alzheimer's disease. Nat Med 31, 2044–2053 (2025).
More news about: Eisai Inc.
Jul 12, 2026, 11:15 ET LEQEMBI® Subcutaneous Autoinjector Clinical Data Supports Similar Efficacy and Safety to IV Formulation in Early Alzheimer's Disease Presented at the Alzheimer's Association International Conference® (AAIC®) 2026
investors.ReferencesAmin L, Harris DA. Aβ receptors specifically recognize molecular features displayed by fibril ends and neurotoxic oligomers. Nat Commun. 2021; 12:3451. doi: 10.1038/s41467-021-23507-z.Ono K, Tsuji M. Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying
More news about: Eisai Inc.
Jul 08, 2026, 12:43 ET Doctor's Best Adds New Magnesium and Creatine Powders to Product Line
10.1016/j.exger.2018.04.0132 Nat Sci Sleep. 2025 Aug 30:17:2027-2040. doi:
More news about: Doctor's Best
Jul 08, 2026, 09:06 ET Gold Above $4,100: The Race To Build Africa's Next Gold Mines Is On
Victoria Gold Ltd. Technical information relating to Lake Victoria Gold Ltd. has been reviewed and approved by the company and David Scott, Pr. Sci. Nat., a Qualified Person as defined by National Instrument 43-101. Mr. Scott is a registered member of the South African Council for Natural Scientific Professions
More news about: Equity Insider
Jun 29, 2026, 08:00 ET 25 Years Later, 9/11 Day Aims to Transform the Anniversary of 9/11 into America's Day of Doing Good
BeautifulLiberty Coca-Cola BeveragesLive NationLove Has No LimitsMajor League BaseballMajor League SoccerNat. Assoc. of Elementary School PrincipalsNational Basketball AssociationNational Football LeagueNational Governors AssociationNational
More news about: 9/11 Day
Jun 29, 2026, 07:30 ET Eisai to Showcase Alzheimer's Disease Portfolio with More Than 50 Presentations at the Alzheimer's Association International Conference® 2026 (AAIC®)
2015.ReferencesAmin L, Harris DA. Aβ receptors specifically recognize molecular features displayed by fibril ends and neurotoxic oligomers. Nat Commun. 2021;12: 3451. doi:10.1038/s41467-021-23507-z.Ono K, Tsuji M. Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying
More news about: Eisai Inc.
Jun 29, 2026, 03:10 ET AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Severe Alopecia Areata
J Am Acad Dermatol. 2010;62(2):177-188, quiz 189-190.Pratt CH, King LE, Messenger AG, Christiano AM, Sundberg JP. Alopecia areata. Nat Rev Dis Primers. 2017;3(1):17011Davey L, Clarke V, Jenkinson E. Living with alopecia areata: an online qualitative survey study. Br J
More news about: AbbVie
Jun 29, 2026, 03:10 ET AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Severe Alopecia Areata
J Am Acad Dermatol. 2010;62(2):177-188, quiz 189-190.Pratt CH, King LE, Messenger AG, Christiano AM, Sundberg JP. Alopecia areata. Nat Rev Dis Primers. 2017;3(1):17011Davey L, Clarke V, Jenkinson E. Living with alopecia areata: an online qualitative survey study. Br J
More news about: AbbVie
Jun 26, 2026, 18:50 ET Gibson anuncia una transición de liderazgo planificada
Directorio, queremos agradecerle por su liderazgo transformador y el importante papel que ha desempeñado en reconstruir las bases de la Empresa", señaló Nat Zilkha, presidente ejecutivo del Directorio de Gibson. "Cesar se integró a nuestro equipo decidido a ir más allá de las funciones operativas para centrar
More news about: Gibson
Jun 25, 2026, 15:20 ET Gibson Announces Planned Leadership Transition
the Board, we thank Cesar for his transformative leadership and the important role he has played in rebuilding the foundation of the Company," said Nat Zilkha, Executive Chairman of Gibson's Board of Directors. "Cesar came to us ready to step back from the day-to-day operating role and focus his energy
More news about: Gibson